WHO ICTRP trial
A Clinical Study to Assess the Effectiveness of Sarpagandha Extract Mansyadi…
CTRI/2026/01/100964 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2026/01/100964 |
|---|---|
| Public title | A Clinical Study to Assess the Effectiveness of Sarpagandha Extract Mansyadi Kwatha and Jaladhara Therapy in the Treatment of Essential Hypertension |
| Scientific title | An Open-Label Randomised Controlled Clinical Study to Evaluate the Efficacy of Sarpagandha Extract Mansyadi Kwatha and Jaladhara in the Management of Essential Hypertension - NIL |
| Primary sponsor | Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola Himachal Pradesh |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: I10- Essential (primary) hypertension |
| Registration date | Jan 13, 2026 |
| Target size | 30 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: